"Designing Growth Strategies is in our DNA"

Exocrine Pancreatic Insufficiency Therapeutics Market Size, Share & Industry Analysis, By Therapy (Pancreatic Enzyme Replacement Therapy (PERT), Nutritional Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Others) and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI100652

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Disorders Associated With Exocrine Pancreatic Insufficiency
    2. Pipeline Analysis
    3. Recent Industry Developments Such as Mergers, Partnerships & Acquisitions
    4. Regulatory Scenario
    5. New Product Launches
  5. Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2024)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Allergan
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. AzurRx
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. CHIESI Farmaceutici S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Disorders Associated With Exocrine Pancreatic Insufficiency
    2. Pipeline Analysis
    3. Recent Industry Developments Such as Mergers, Partnerships & Acquisitions
    4. Regulatory Scenario
    5. New Product Launches
  5. Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
      1. Pancreatic Enzyme Replacement Therapy (PERT)
        1. Creon
        2. Zenpep
        3. Others
      2. Nutritional Therapy
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Others
    4. Market Analysis – By Country
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2024)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Allergan
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. AzurRx
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. CHIESI Farmaceutici S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 1:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue Breakdown (US$ Mn, %) by Region, 2024 & 2032

Figure 2:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2024 & 2032

Figure 3:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Pancreatic Enzyme Replacement Therapy (PERT), 2019-2032

Figure 4:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Nutritional Therapy, 2019-2032

Figure 5:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 6:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Hospital Pharmacies, 2019-2032

Figure 7:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Retail Pharmacies & Drug Stores, 2019-2032

Figure 8:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Others, 2019-2032

Figure 9:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Region, 2024 & 2032

Figure 10:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2024 & 2032

Figure 11:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2024

Figure 12:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 13:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2024

Figure 14:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country, 2024 & 2032

Figure 15:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country, 2024

Figure 16:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2024 & 2032

Figure 17:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2024

Figure 18:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 19:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2024

Figure 20:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 21:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 22:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2024 & 2032

Figure 23:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2024

Figure 24: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 25: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2024

Figure 26:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 27:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 28:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2024 & 2032

Figure 29:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2024

Figure 30:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 31:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2024

Figure 32:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Share (%), By Company, 2024

Table 1:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2019–2032

Table 2:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2019–2032

Table 3:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019–2032

Table 4:  Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Region, 2019-2032

Table 5:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2019-2032

Table 6:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2019–2032

Table 7:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 8:  North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country, 2019-2032

Table 9:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2019-2032

Table 10:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2019–2032

Table 11:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 12:  Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 13:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2019-2032

Table 14:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2019–2032

Table 15:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 16:  Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 17:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2019-2032

Table 18:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2019–2032

Table 19:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 20:  Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Exocrine Pancreatic Insufficiency Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 128
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports